Hoffmann, Ulrike
Clemens, Vera
König, Elisa
Brähler, Elmar
Fegert, Jörg M.
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 16 June 2020
Accepted: 23 October 2020
First Online: 6 November 2020
Consent for publication
: Not applicable.
: UH, VC, EK and EB state that they have no conflict of interests.JMF has received research funding from the EU, DFG (German Research Foundation), BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), BfArM (Federal Institute for Drugs and Medical Devices), German armed forces, several state ministries of social affairs, State Foundation Baden-Württemberg, Volkswagen Foundation, Pontifical Gregorian University, CJD, Caritas, Diocese of Rottenburg-Stuttgart. Moreover, he received travel grants, honoraria and sponsoring for conferences and medical educational purposes from DFG, AACAP, NIMH/NIH, EU, Pro Helvetia, Shire, several universities, professional associations, political foundations, and German federal and state ministries during the last 5 years. Every grant and every honorarium has to be declared to the law office of the University Hospital Ulm. Professor Fegert holds no stocks of pharmaceutical companies.BV has been consultant for Medice and Lundeck Pharmaceuticals, and for law firms Goodwin & Procter and Haynes & Boone. He holds no stocks of pharmaceutical companies.